| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/12/2004 | US20040028646 Polyoxyethylene glycol |
| 02/12/2004 | US20040028625 Transdermal delivery of analgesics |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028618 Powder aerosol mixture containing propellant gas mixtures |
| 02/12/2004 | US20040028617 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | US20040025876 Capsules for dry powder inhalers and methods of making and using same |
| 02/12/2004 | DE19949252B4 Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung Use of a superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases and process for its preparation |
| 02/12/2004 | DE10234975A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis |
| 02/12/2004 | DE10154016B4 Magnetflüssigkeit und Verfahren zur ihrer Herstellung Magnetic fluid and process for its preparation |
| 02/12/2004 | CA2494801A1 Medicinal composition containing hmg-coa reductase inhibitor |
| 02/12/2004 | CA2494342A1 Injectable depot compositions and uses thereof |
| 02/12/2004 | CA2494316A1 Improved injection system |
| 02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | CA2494281A1 Sustained release formulations of metformin |
| 02/12/2004 | CA2494277A1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | CA2494212A1 Oral administration of calcitonin |
| 02/12/2004 | CA2494017A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | CA2493593A1 Bicifadine formulation |
| 02/12/2004 | CA2493301A1 Sustained release formulations comprising lamotrigine |
| 02/12/2004 | CA2492437A1 New effector conjugates, process for their production and their pharmaceutical use |
| 02/12/2004 | CA2491366A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388371A2 A dispensing device and method for forming material |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1387703A1 Fibrin material and method for producing and using the same |
| 02/11/2004 | EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 02/11/2004 | EP1387699A1 Agent for improving tissue penetration |
| 02/11/2004 | EP1387677A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1387675A2 Liquid formulation of metformin |
| 02/11/2004 | EP1387673A1 Abuse-resistant controlled-release opioid dosage form |
| 02/11/2004 | EP1387670A2 Immune modulation device for use in animals |
| 02/11/2004 | EP1387665A2 System for delivering cosmetics and pharmaceuticals |
| 02/11/2004 | EP1300394B1 Method for the production of a water-dispersible formulation containing carotenoids |
| 02/11/2004 | EP1257259A4 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 02/11/2004 | EP1227795B1 Lipid complex of alkycyclines |
| 02/11/2004 | EP1204634B1 Branched, substantially unsaturated fatty alcohol sulfates |
| 02/11/2004 | EP1180033B1 Lamivudine containing pharmaceutical formulation |
| 02/11/2004 | EP1176962B1 Liposome compositions for improved drug retention |
| 02/11/2004 | EP1126822B1 Controlled release liquid delivery compositions with low initial drug burst |
| 02/11/2004 | EP1123087A4 Oral pulsed dose drug delivery system |
| 02/11/2004 | EP1083937B1 Radioioinated phenols for brachytherapy |
| 02/11/2004 | EP1079808B1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 02/11/2004 | EP0909177B1 Aqueous formulations of peptides |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth |
| 02/11/2004 | CN1474703A Taxoid conjugates as antimitotic and antitumor agents |
| 02/11/2004 | CN1474702A Oral pharmaceutical composition containing a block copolymer |
| 02/11/2004 | CN1474700A Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 02/11/2004 | CN1474698A Formulation containing phosphate derivatives of electron transfer agents |
| 02/11/2004 | CN1474697A Complexes of phosphate derivatives |
| 02/11/2004 | CN1474687A Mdeicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 02/11/2004 | CN1474686A Hydrolytically unstable compositions |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1473742A Injection molded water soluble container |
| 02/11/2004 | CN1473560A Mouth cavity fast disintegrating tablet of Chinese medicine or natural medical matters and its preparing method |
| 02/11/2004 | CN1473558A Compound function supermicro magnetic carrier particle and its preparing method |
| 02/11/2004 | CN1137730C Matrix of Chinese medicine plaster and its preparation technology |
| 02/11/2004 | CN1137729C Fine grain carrier and medicinal composition prepared with use of same |
| 02/11/2004 | CN1137723C Enhanced wound coverage and composition to enhance wound healing |
| 02/11/2004 | CN1137689C Drug delivery compositions for stability of steroids |
| 02/11/2004 | CN1137687C Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 02/11/2004 | CN1137685C Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 02/11/2004 | CN1137684C Pharmaceutical composition stabilized with basic agent |
| 02/11/2004 | CN1137680C Aerosol compositions |
| 02/11/2004 | CN1137679C 水溶性滴眼剂 Water-soluble eye drops |
| 02/10/2004 | US6689884 Supramolecular pairing system, its preparation and use |
| 02/10/2004 | US6689803 Administering anti-microtubule compound-containing, pharmaceutically acceptable formulation wherein anti-microtubule compound is paclitaxel for therapy and prophylaxis of surgical adhesions |
| 02/10/2004 | US6689755 Method of stabilizing biologically active substances |
| 02/10/2004 | US6689747 Use of insulin for the treatment of cartilagenous disorders |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689600 Formulation of adenovirus for gene therapy |
| 02/10/2004 | US6689400 Sovent extracting the dried marigold flower petals, eluting through an anion exchange resin column, diluting the eluent, crystallization; protecting lutein against deterioration, store for long time |
| 02/10/2004 | US6689399 Capsacinoid in conjunction with glucosamine at a high concentration, synergistic; prolonged pain relief effect is achieved without intense burning or stinging sensation usually associated with topical capsaicin |
| 02/10/2004 | US6689390 A lipid or other hydrophobic or amphiphilic compound is integrated into a polymeric matrix for drug delivery to alter drug release kinetics. In embodiments where the drug is water soluble, the drug is released over longer periods of time as |
| 02/10/2004 | US6689389 Pharmaceutically acceptable starch |
| 02/10/2004 | US6689386 Such as ibuprofen |
| 02/10/2004 | US6689384 Stable pergolide mesylate and process for making same |
| 02/10/2004 | US6689381 Liposome comprising phosphatidylcholine, cholesterol, as well as benzoquinazoline thymidylate synthase inhibitor; improved pharmacokinetics and efficacy as anti-tumor agents compared to free drug |
| 02/10/2004 | US6689379 Transdermal therapeutic system with neutralized acrylic adhesive patch |
| 02/10/2004 | US6689373 Implanting a drug delivery device; fentanyl or a fentanyl congener (e.g., sufentanil) |
| 02/10/2004 | US6689371 Nanoemulsion based on sugar fatty esters or on sugar fatty ethers and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 02/10/2004 | US6689370 Vaccine adjuvant is a zinc, manganese or calcium salt of gluconic acid, fructoheptonic acid or glucoheptonic acid |
| 02/10/2004 | US6689362 Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP) |
| 02/10/2004 | US6689353 Stabilized with histidine, glycine and sucrose |
| 02/10/2004 | US6689350 Therapeutic polyesters and polyamides |
| 02/10/2004 | US6689349 Aging, ultraviolet radiation |
| 02/10/2004 | US6689339 Freckles |
| 02/10/2004 | US6689338 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/10/2004 | US6689299 Process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 02/10/2004 | CA2372576C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 02/10/2004 | CA2359812C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| 02/10/2004 | CA2180301C Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 02/10/2004 | CA2134196C Pharmaceutical preparation and process for its manufacture |
| 02/10/2004 | CA2109053C Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers |
| 02/10/2004 | CA2106474C Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 02/10/2004 | CA2070061C Physiologically active polypeptide-containing pharmaceutical composition |
| 02/10/2004 | CA2054955C Cosmetic, pharmaceutic or food composition comprising a lipid vesicles dispersion |